ID   M3K13_HUMAN             Reviewed;         966 AA.
AC   O43283; B2R6U2; B4DLE3; B4DMV2; B4DZJ4; D3DNU1; Q05BY6; Q15450; Q2NKN3;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   12-OCT-2022, entry version 179.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 13;
DE            EC=2.7.11.25;
DE   AltName: Full=Leucine zipper-bearing kinase;
DE   AltName: Full=Mixed lineage kinase;
DE            Short=MLK;
GN   Name=MAP3K13 {ECO:0000312|HGNC:HGNC:6852};
GN   Synonyms=LZK {ECO:0000312|EMBL:BAA24817.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAA24817.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   ACTIVITY REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   AUTOPHOSPHORYLATION.
RC   TISSUE=Cerebellum {ECO:0000269|PubMed:9353328};
RX   PubMed=9353328; DOI=10.1074/jbc.272.45.28622;
RA   Sakuma H., Ikeda A., Oka S., Kozutsumi Y., Zanetta J., Kawasaki T.;
RT   "Molecular cloning and functional expression of a cDNA encoding a new
RT   member of mixed lineage protein kinase from human brain.";
RL   J. Biol. Chem. 272:28622-28629(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 230-340 (ISOFORM 1).
RX   PubMed=8274451;
RA   Schultz S.J., Nigg E.A.;
RT   "Identification of 21 novel human protein kinases, including 3 members of a
RT   family related to the cell cycle regulator nimA of Aspergillus nidulans.";
RL   Cell Growth Differ. 4:821-830(1993).
RN   [7] {ECO:0000305}
RP   HOMODIMERIZATION.
RX   PubMed=11163770; DOI=10.1016/s0014-5793(00)02432-7;
RA   Ikeda A., Masaki M., Kozutsumi Y., Oka S., Kawasaki T.;
RT   "Identification and characterization of functional domains in a mixed
RT   lineage kinase LZK.";
RL   FEBS Lett. 488:190-195(2001).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH MAPK8IP1.
RX   PubMed=11726277; DOI=10.1093/oxfordjournals.jbchem.a003048;
RA   Ikeda A., Hasegawa K., Masaki M., Moriguchi T., Nishida E., Kozutsumi Y.,
RA   Oka S., Kawasaki T.;
RT   "Mixed lineage kinase LZK forms a functional signaling complex with JIP-1,
RT   a scaffold protein of the c-Jun NH(2)-terminal kinase pathway.";
RL   J. Biochem. 130:773-781(2001).
RN   [9] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH PRDX3, AND MUTAGENESIS OF LYS-195.
RX   PubMed=12492477; DOI=10.1046/j.1432-1033.2003.03363.x;
RA   Masaki M., Ikeda A., Shiraki E., Oka S., Kawasaki T.;
RT   "Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB
RT   synergistically.";
RL   Eur. J. Biochem. 270:76-83(2003).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-517; LYS-712 AND LEU-746.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Activates the JUN N-terminal pathway through activation of
CC       the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to
CC       regulate the activation of NF-kappa-B in the cytosol. This activation
CC       is kinase-dependent and involves activating the IKK complex, the IKBKB-
CC       containing complex that phosphorylates inhibitors of NF-kappa-B.
CC       {ECO:0000269|PubMed:11726277, ECO:0000269|PubMed:12492477,
CC       ECO:0000269|PubMed:9353328}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC         Evidence={ECO:0000269|PubMed:9353328};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25; Evidence={ECO:0000269|PubMed:9353328};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q60700};
CC   -!- ACTIVITY REGULATION: Activated by autophosphorylation and
CC       homodimerization. {ECO:0000269|PubMed:11163770,
CC       ECO:0000269|PubMed:9353328}.
CC   -!- SUBUNIT: Homodimer; forms dimers through the leucine-zipper motif.
CC       Interacts with the C-terminus of MAPK8IP1 through the kinase catalytic
CC       domain. Binds PRDX3. Associates with the IKK complex through the kinase
CC       domain. {ECO:0000269|PubMed:11163770, ECO:0000269|PubMed:11726277,
CC       ECO:0000269|PubMed:12492477}.
CC   -!- INTERACTION:
CC       O43283; O43283: MAP3K13; NbExp=2; IntAct=EBI-1168480, EBI-1168480;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9353328}. Membrane
CC       {ECO:0000269|PubMed:9353328}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O43283-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43283-3; Sequence=VSP_036567, VSP_036568;
CC       Name=3;
CC         IsoId=O43283-4; Sequence=VSP_036563, VSP_036566;
CC       Name=4;
CC         IsoId=O43283-5; Sequence=VSP_036562, VSP_036569;
CC       Name=5;
CC         IsoId=O43283-6; Sequence=VSP_036564, VSP_036565;
CC   -!- TISSUE SPECIFICITY: Expressed in the adult brain, liver, placenta and
CC       pancreas, with expression strongest in the pancreas.
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC       {ECO:0000269|PubMed:9353328}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI11727.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=BAG59505.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB001872; BAA24817.1; -; mRNA.
DR   EMBL; AK296961; BAG59505.1; ALT_SEQ; mRNA.
DR   EMBL; AK297646; BAG60014.1; -; mRNA.
DR   EMBL; AK302951; BAG64106.1; -; mRNA.
DR   EMBL; AK312714; BAG35589.1; -; mRNA.
DR   EMBL; AC099661; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78224.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78225.1; -; Genomic_DNA.
DR   EMBL; BC031677; AAH31677.1; -; mRNA.
DR   EMBL; BC111726; AAI11727.1; ALT_SEQ; mRNA.
DR   EMBL; Z25428; CAA80915.1; -; mRNA.
DR   CCDS; CCDS3270.1; -. [O43283-1]
DR   CCDS; CCDS56298.1; -. [O43283-5]
DR   PIR; I38218; I38218.
DR   RefSeq; NP_001229243.1; NM_001242314.1. [O43283-1]
DR   RefSeq; NP_001229246.1; NM_001242317.1. [O43283-5]
DR   RefSeq; NP_004712.1; NM_004721.4. [O43283-1]
DR   RefSeq; XP_011511612.1; XM_011513310.2. [O43283-1]
DR   RefSeq; XP_016862945.1; XM_017007456.1. [O43283-1]
DR   AlphaFoldDB; O43283; -.
DR   SMR; O43283; -.
DR   BioGRID; 114614; 21.
DR   IntAct; O43283; 27.
DR   STRING; 9606.ENSP00000265026; -.
DR   BindingDB; O43283; -.
DR   ChEMBL; CHEMBL1163124; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; O43283; -.
DR   GuidetoPHARMACOLOGY; 2073; -.
DR   GlyGen; O43283; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O43283; -.
DR   PhosphoSitePlus; O43283; -.
DR   BioMuta; MAP3K13; -.
DR   jPOST; O43283; -.
DR   MassIVE; O43283; -.
DR   PaxDb; O43283; -.
DR   PeptideAtlas; O43283; -.
DR   PRIDE; O43283; -.
DR   ProteomicsDB; 48852; -. [O43283-1]
DR   ProteomicsDB; 48853; -. [O43283-3]
DR   ProteomicsDB; 48854; -. [O43283-4]
DR   ProteomicsDB; 48855; -. [O43283-5]
DR   ProteomicsDB; 48856; -. [O43283-6]
DR   Antibodypedia; 33834; 305 antibodies from 26 providers.
DR   DNASU; 9175; -.
DR   Ensembl; ENST00000265026.8; ENSP00000265026.3; ENSG00000073803.14. [O43283-1]
DR   Ensembl; ENST00000424227.5; ENSP00000399910.1; ENSG00000073803.14. [O43283-1]
DR   Ensembl; ENST00000433092.5; ENSP00000389798.1; ENSG00000073803.14. [O43283-6]
DR   Ensembl; ENST00000438053.5; ENSP00000403561.1; ENSG00000073803.14. [O43283-3]
DR   Ensembl; ENST00000443863.5; ENSP00000409325.1; ENSG00000073803.14. [O43283-4]
DR   Ensembl; ENST00000446828.5; ENSP00000411483.1; ENSG00000073803.14. [O43283-5]
DR   GeneID; 9175; -.
DR   KEGG; hsa:9175; -.
DR   MANE-Select; ENST00000265026.8; ENSP00000265026.3; NM_004721.5; NP_004712.1.
DR   UCSC; uc003fph.5; human. [O43283-1]
DR   CTD; 9175; -.
DR   DisGeNET; 9175; -.
DR   GeneCards; MAP3K13; -.
DR   HGNC; HGNC:6852; MAP3K13.
DR   HPA; ENSG00000073803; Low tissue specificity.
DR   MIM; 604915; gene.
DR   neXtProt; NX_O43283; -.
DR   OpenTargets; ENSG00000073803; -.
DR   PharmGKB; PA30596; -.
DR   VEuPathDB; HostDB:ENSG00000073803; -.
DR   eggNOG; KOG4721; Eukaryota.
DR   GeneTree; ENSGT00940000158216; -.
DR   HOGENOM; CLU_1869795_0_0_1; -.
DR   InParanoid; O43283; -.
DR   OMA; KYPGTCK; -.
DR   OrthoDB; 938929at2759; -.
DR   PhylomeDB; O43283; -.
DR   TreeFam; TF105119; -.
DR   PathwayCommons; O43283; -.
DR   SignaLink; O43283; -.
DR   SIGNOR; O43283; -.
DR   BioGRID-ORCS; 9175; 14 hits in 1106 CRISPR screens.
DR   ChiTaRS; MAP3K13; human.
DR   GeneWiki; MAP3K13; -.
DR   GenomeRNAi; 9175; -.
DR   Pharos; O43283; Tchem.
DR   PRO; PR:O43283; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O43283; protein.
DR   Bgee; ENSG00000073803; Expressed in corpus epididymis and 199 other tissues.
DR   ExpressionAtlas; O43283; baseline and differential.
DR   Genevisible; O43283; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0106137; F:IkappaB kinase complex binding; IDA:UniProtKB.
DR   GO; GO:0004706; F:JUN kinase kinase kinase activity; IBA:GO_Central.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; ISS:ARUK-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:ARUK-UCL.
DR   GO; GO:1905492; P:positive regulation of branching morphogenesis of a nerve; ISS:ARUK-UCL.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0014042; P:positive regulation of neuron maturation; ISS:ARUK-UCL.
DR   GO; GO:0150012; P:positive regulation of neuron projection arborization; ISS:ARUK-UCL.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017419; MAP3K12_MAP3K13.
DR   InterPro; IPR027258; MAPKKK13.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF038165; MAPKKK12_MAPKKK13; 1.
DR   PIRSF; PIRSF500742; MAPKKK13; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..966
FT                   /note="Mitogen-activated protein kinase kinase kinase 13"
FT                   /id="PRO_0000086264"
FT   DOMAIN          168..409
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          30..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          90..114
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          433..454
FT                   /note="Leucine-zipper 1"
FT   REGION          486..507
FT                   /note="Leucine-zipper 2"
FT   REGION          534..599
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          611..655
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          744..834
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          815..828
FT                   /note="Acidic"
FT                   /evidence="ECO:0000305"
FT   REGION          846..908
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        96..114
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        560..582
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        846..863
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        864..887
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        279
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q12852,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         174..182
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q12852,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         195
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q60700,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         1..207
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036562"
FT   VAR_SEQ         1..144
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036563"
FT   VAR_SEQ         122..128
FT                   /note="RSGSGSG -> RYLGSAI (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036564"
FT   VAR_SEQ         129..966
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036565"
FT   VAR_SEQ         145..159
FT                   /note="IGKAYSTDYKLQQQD -> MSYVECKCLQLENKN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036566"
FT   VAR_SEQ         159..160
FT                   /note="DT -> VF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036567"
FT   VAR_SEQ         161..966
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036568"
FT   VAR_SEQ         208..220
FT                   /note="LRKLKHPNIIAFK -> MYCGIQILALWER (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036569"
FT   VARIANT         44
FT                   /note="E -> K (in dbSNP:rs35266179)"
FT                   /id="VAR_051640"
FT   VARIANT         517
FT                   /note="R -> G (in dbSNP:rs56408536)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040708"
FT   VARIANT         712
FT                   /note="E -> K (in dbSNP:rs56309231)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040709"
FT   VARIANT         746
FT                   /note="P -> L (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040710"
FT   VARIANT         915
FT                   /note="R -> H (in dbSNP:rs3732576)"
FT                   /id="VAR_030577"
FT   MUTAGEN         195
FT                   /note="K->A: Kinase inactive. Fails to activate
FT                   NF-kappa-B."
FT                   /evidence="ECO:0000269|PubMed:12492477"
FT   CONFLICT        106
FT                   /note="D -> G (in Ref. 2; BAG59505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230..232
FT                   /note="CII -> YLY (in Ref. 6; CAA80915)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="N -> D (in Ref. 2; BAG59505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        339..340
FT                   /note="FG -> MV (in Ref. 6; CAA80915)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        508
FT                   /note="E -> G (in Ref. 2; BAG64106)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        821
FT                   /note="G -> R (in Ref. 2; BAG60014)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   966 AA;  108296 MW;  9687F38C8AB20AB1 CRC64;
     MANFQEHLSC SSSPHLPFSE SKTFNGLQDE LTAMGNHPSP KLLEDQQEKG MVRTELIESV
     HSPVTTTVLT SVSEDSRDQF ENSVLQLREH DESETAVSQG NSNTVDGEST SGTEDIKIQF
     SRSGSGSGGF LEGLFGCLRP VWNIIGKAYS TDYKLQQQDT WEVPFEEISE LQWLGSGAQG
     AVFLGKFRAE EVAIKKVREQ NETDIKHLRK LKHPNIIAFK GVCTQAPCYC IIMEYCAHGQ
     LYEVLRAGRK ITPRLLVDWS TGIASGMNYL HLHKIIHRDL KSPNVLVTHT DAVKISDFGT
     SKELSDKSTK MSFAGTVAWM APEVIRNEPV SEKVDIWSFG VVLWELLTGE IPYKDVDSSA
     IIWGVGSNSL HLPVPSTCPD GFKILMKQTW QSKPRNRPSF RQTLMHLDIA SADVLATPQE
     TYFKSQAEWR EEVKKHFEKI KSEGTCIHRL DEELIRRRRE ELRHALDIRE HYERKLERAN
     NLYMELSAIM LQLEMREKEL IKREQAVEKK YPGTYKRHPV RPIIHPNAME KLMKRKGVPH
     KSGMQTKRPD LLRSEGIPTT EVAPTASPLS GSPKMSTSSS KSRYRSKPRH RRGNSRGSHS
     DFAAILKNQP AQENSPHPTY LHQAQSQYPS LHHHNSLQQQ YQQPPPAMSQ SHHPRLNMHG
     QDIATCANNL RYFGPAAALR SPLSNHAQRQ LPGSSPDLIS TAMAADCWRS SEPDKGQAGP
     WGCCQADAYD PCLQCRPEQY GSLDIPSAEP VGRSPDLSKS PAHNPLLENA QSSEKTEENE
     FSGCRSESSL GTSHLGTPPA LPRKTRPLQK SGDDSSEEEE GEVDSEVEFP RRQRPHRCIS
     SCQSYSTFSS ENFSVSDGEE GNTSDHSNSP DELADKLEDR LAEKLDDLLS QTPEIPIDIS
     SHSDGLSDKE CAVRRVKTQM SLGKLCVEER GYENPMQFEE SDCDSSDGEC SDATVRTNKH
     YSSATW
//
